Inhaled Corticosteroid Escalation After a Single Moderate Exacerbation in COPD: Differential Benefit by Exacerbation Subtype
Sep 07, 2026

In this study, the benefit of ICS escalation after single moderate exacerbation varied by exacerbation treatment phenotype. Steroid-treated events were associated with a reduced subsequent exacerbation with ICS escalation, whereas antibiotic-treated events did not confer additional benefit from ICS, supporting a more precise approach to ICS escalation beyond exacerbation frequency alone.


Lung Sask in collaboration with RESPTREC® offers the Professional Education Portal as a method for respiratory educators and health care providers to enhance their professional learning with continuing education opportunities.

Over 6000+ more articles available in the Professional Education Portal.

Read articles and watch video presentations on the most recent research, position papers and guidelines. Track your CE time with the provided logbook.

Access this free resource